New symptoms surface in Ebola patients months after initial recovery Survivors of infection by Ebola virus, already known to face vision, hearing and other problems during their recovery, may also be plagued with health issues such as depression, anxiety and nerve damage that surface after they leave the hospital, according to a small spot survey of victims whose care was managed in the U.S. Some of the signs and symptoms can persist for months, researchers from the Centers for Disease Control and Prevention in Atlanta found.
Shingles linked to increased risk of heart attack, stroke A bout of shingles may increase your risk for other serious health conditions — namely, a stroke or a heart attack — a new study finds.
New coffee offers same heart benefit as red wine, chemist says A University of New Hampshire chemist says he's developed a coffee that provides the same benefits to the heart as red wine.
Optimism good for your heart, but gratitude, not so much After surviving a heart attack or severe blockage of blood flow to the heart, optimistic people are more likely to make healthy lifestyle changes and less likely to end up back in the hospital, a U.S. study suggests.
'Social jet lag' linked to risk of diabetes and heart disease Need another reason to loathe your alarm clock?
Second language linked to better brain function after stroke People who speak two languages are twice as likely as those who only speak one to regain normal cognitive function after a stroke, according to a new study.
Implantable air valves help some emphysema patients breathe easier An experimental treatment for severe emphysema that involves placing one-way valves in airways leading to damaged lung tissue can help patients breathe easier and exercise longer, according to a new study from the Netherlands The technique is designed to replace risky surgery in which doctors remove a damaged lobe of the lung to literally give healthier areas more breathing room.
Once-a-week diabetes meds are similar in safety and effectiveness There's little difference in the performance of five new once-a-week drugs to treat diabetes when they're compared to one another, though small differences in side effects emerge, according to a new review of existing evidence.
FDA approves Baxalta's treatment for common bleeding disorder The U.S. Food and Drug Administration on Tuesday approved Baxalta Inc's Vonvendi, making it the first engineered protein-based treatment for the world's most common inherited bleeding disorder.
Childhood allergies could signal heart disease risk Children who have asthma, hay fever or eczema may also have more risk factors for heart disease at a young age, as compared to kids who don't have these allergy-related conditions, a new study suggests.
